July 1, 2026
ImmunoForge to Accelerate CNS Drug Development with Innovative BBB Shuttle Platform ‘LMT15’
B ImmunoForge’s LMT15 Platform combines high BBB permeability with proprietary long-acting ELP technology Technology excellence validated by winning first place at ‘Novo Nordisk Partnering Day…
